Afnan: 2010 – A Time for Reflection
The underlying challenges that drug manufacturers face, the real-time control of attributes critical to quality, still remain. In the first installment for PharmaQbD.com, Ali Afnan takes a moment to...
View ArticleWhat Will the FDA Say? Time to Change the Question
Ask not what FDA will say about our products and processes, says Contributing Editor Ali Afnan, but rather what we can demonstrate to the Agency. Change depends on it.
View Article
More Pages to Explore .....
